869
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells

, , , , , , , ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 289-299 | Received 13 Mar 2020, Accepted 03 Jul 2020, Published online: 27 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xu Hao, Yuanyuan Li, Jialu Bian, Ying Zhang, Shiyu He, Feng Yu, Yufei Feng & Lin Huang. (2022) Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy. Drug Metabolism Reviews 54:2, pages 194-206.
Read now

Articles from other publishers (3)

Rive Sarfstein, Karthik Nagaraj, Shivang Parikh, Carmit Levy, Zvi Laron, Dafna Benayahu & Haim Werner. (2022) Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action. Cells 11:10, pages 1627.
Crossref
Brenna M. Zimmer, Michelle E. Howell, Linlin Ma, Jeffrey R. Enders, Danielle Lehman, Eva Corey, Joseph J. Barycki & Melanie A. Simpson. (2021) Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer. Oncotarget 12:19, pages 1886-1902.
Crossref
Yingjie Shen, Hyoung Jae Lee, Rui Zhou, Hangun Kim, Gen Chen, Young-Chang Cho & Kwonseop Kim. (2021) δ-Catenin Participates in EGF/AKT/p21Waf Signaling and Induces Prostate Cancer Cell Proliferation and Invasion. International Journal of Molecular Sciences 22:10, pages 5306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.